Macleods Pharmaceuticals Limited IPO - Details

Macleods Pharmaceuticals Limited IPO has been filed with the capital market regulator SEBI for Rs.5,000 crore. This is going to be the second most IPO that has been raised by a Pharma after Gland’s Pharma Rs.6,480 Cr issue. Macleods Pharmaceuticals Limited is one of the seventh-largest drug pharma companies in the Indian Pharmaceutical Market.

Opening Date:

To be announced

Issue Size:

To be announced

Closing Date:

To be announced

Face Value:

To be announced

Price Band:

To be announced

Market Lot:

To be announced

Opening Date:

To be announced

Issue Size:

To be announced

Closing Date:

To be announced

Face Value:

To be announced

Price Band:

To be announced

Market Lot:

To be announced

Listing at NSE, BSE

Macleods Pharmaceuticals Limited IPO Important Dates:

IPO Open Date To be announced
IPO Close Date To be announced
Allotment Date To be announced
Initiation of Refunds To be announced
Credit of shares to Demat Account To be announced
Ipo Listing Date To be announced
UPI Mandate Expiry Date To be announced

View all upcoming IPOs

About Macleods Pharmaceuticals Limited

Established in 1989, Macleods Pharmaceuticals are into developing, manufacturing and marketing an extensive range of pharmaceutical products. Their product portfolio includes the major therapeutic areas like anti-infectives, cardiovascular, dermatology, hormone treatment, etc. The brand has the highest number of WHO prequalified products globally with 65 registrations.

The brand has an extensive presence across the globe. Macleods Pharmaceuticals is present in more than 170 countries such as Africa, Europe, Asia, North America, etc. In India, the operations are supported by eight manufacturing units. The 8 manufacturing units have a vast range of oral dosage forms and complex formulations, such as topicals, injectables and inhalers.

Macleods Pharmaceuticals IPO Objectives

Here are a few quick reasons why Macleods Pharmaceuticals going public:

  • The fund will be used to increase the brand visibility and image of the company

  • The IPO will provide a public market for the equity shares in India

Why should you invest in the Macleods Pharmaceuticals IPO?

  • From FY2011 to FY 2021, the company has outperformed The IPM with the domestic Sales growth at a CAGR of 15.3%
  • In Fiscal 2021, 14 brands out of 595 brands earned more than ₹ 500 million in Domestic Sales
  • The brand has a diversified portfolio in terms of geography, product portfolio and business model

Financial Highlights

Metrics

2019

2020

2021

 

(₹ million, except percentages)

Revenue from operations

58,704.35

69,028.16

71,994.16

India

35,168.28

39,281.75

37,245.16

Outside India

23,536.07

29,746.41

34,749.00

EBITDA

13,408.93

17,243.18

20,966.60

EBITDA Margin

22.84%

24.98%

29.12%

PAT

11,921.30

14,611.95

16,307.18

PAT Margin

20.31%

21.17%

22.65%

ROCE

58.68%

65.49%

66.05%

Fixed Asset

Turnover

6.10

6.68

5.69

How to apply for the Macleods IPO?

There are two ways by which investors can choose to start trading. One is through UPI, and the other is with the help of a Demat account. The processes are discussed below:

UPI

  • Link your bank account to a UPI ID.
  • Register your UPI id with your Demat account.
  • Subscribe for Macleods Pharmaceuticals IPO and approve the payment on your UPI ID.

Demat Account

Macleods Pharmaceuticals Noteworthy Highlights:

  • The brand has maintained its position for five consecutive year as 2nd largest company in the Cover Market in the IPM

  • Their one of the top brands Panderm++, dermatology formulation, has crossed ₹ 1 billion in Domestic Sales in FY21

The Brand’s Pros & Cons

Pros

Cons

The brand has a strong R&D resulting in an amazing track record of product innovation and product launches

Any shortfall of raw materials or an increase of price, may affect the business

Their in-house packaging material unit helps the company in quality checks and quality control across the various stages of operations.

Any pharma manufacturers are subject to significant regulatory scrutiny. The introduction of any law from the regulatory bodies can impact the business adversely.

The company has an experienced and professional management team that helps in building brands

Changes in government regulation can affect the business

The company is one of the leading and fastest-growing companies, being among the top 10 Indian pharmaceutical companies

As the brand is dependent on third-party manufacturers, any delays or disruptions in the manufacturing facilities will affect the business

The company has a diversified presence across the global market existing in 170 countries

As the brand is heavily dependent on R&D, any setback in the department can affect the company

Competitive Analysis Market Peer

Though the brand is performing outstandingly, the brand has its set of the competitors. The below table depicts Domestic Sales by metros and non-metro of the market peers and Macleods Pharmaceuticals:

Company

% Contribution to Total Domestic Sales (Fiscal 2021)

Metro

Non-Metro

Sun Pharmaceuticals Industries LTD

29.9%

70.1%

Cipla LTD

35.2%

64.8%

Alkem Laboratories LTD

22.0%

78.0%

Lupin Limited

37.0%

63.0%

Torrent Pharma

31.0%

69.0%

Macleods Pharmaceuticals Limited

20.0%

80.0%

Frequently Asked Question

What is Macleods Pharmaceuticals IPO?

Macleods Pharmaceuticals Limited IPO has been filed with the capital market regulator SEBI for Rs.5,000 crore.

When will Macleods Pharmaceuticals IPO allotment be available?

Details not available.

What will be the Macleods Pharmaceuticals IPO lot size?

Details not available.

When will Macleods Pharmaceuticals IPO open for subscription?

Details not available.

What minimum lot size can retail investors subscribe to?

Details not available.

When will Macleods Pharmaceuticals list on exchanges?

It usually takes ten working days from the last day of subscription to list the stocks on the exchange.

How to check the allotment status of Macleods Pharmaceuticals IPO?

Investors can visit the IPO register's website or BSE/NSE website to check IPO allotment status. Keep your application number, DP id, and PAN number available when checking allotment status.

If you are an existing Angel One client, you can check the IPO allotment status by logging in to the customer account.

What would be the listing gains on Macleods Pharmaceuticals IPO?

There is no guarantee that the share will list with gain. It depends on the demand for the IPO, global factors, and the short-term outlook, among other factors.

I have finished the application process for Macleods Pharmaceuticals IPO, but the funds are not yet debited. What is the reason?

Your account isn't debited because the bank only blocks the fund when you apply. The amount will be debited if IPO shares are allotted to you, or they will unblock it on the UPI mandate expiration date.

Can I alter my bid for Macleods Pharmaceuticals’ IPO after confirming its final application?

Yes, it is possible to alter the price and lot size. Use the changing/revising the application form that comes with the application kit.

Can I submit more than one application for the public issue of Macleods Pharmaceuticals using one PAN?

No. investors can submit only one application against one PAN card.

Who is the owner of Macleods Pharmaceuticals?

The directors of Macleods Pharmaceuticals are Girdhari Lal Bawri, Rajendra Agarwal and Banwari Lal Bawri.

Enjoy Zero Brokerage on
Stock Investments

Get the link to download the app

Enjoy Lifetime Free Delivery Trade

Download the app now

Or Scan below QR Code

to download App